Results 1 to 10 of about 126,591 (208)

Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT

Health Technology Assessment, 2020
Background: There are around 40,000 new cases of malignant pleural effusion in the UK each year. Insertion of talc slurry via a chest tube is the current standard treatment in the UK.
Rahul Bhatnagar, Ramon Luengo-Fernandez, Brennan C Kahan, Najib M Rahman, Robert F Miller, Nick A Maskell   +5 more
doaj   +10 more sources

Talc slurry versus thoracoscopic talc insufflation for malignant pleural effusion: a systematic review and meta-analysis [PDF]

Jornal Brasileiro de Pneumologia
Objective: Talc pleurodesis is a widely used treatment option for malignant pleural effusion (MPE). However, the optimal form of administration remains controversial. Thus, we performed a systematic review and meta-analysis to assess the effectiveness of
Anna Luíza Soares de Oliveira Rodrigues, Maria Eduarda Cavalcanti Souza, Francisco Cezar Aquino de Moraes, David Paes de Lima, Rafael Lucas Costa de Carvalho   +4 more
doaj   +5 more sources

Intrapleural Fibrinolytic Therapy Improves Results With Talc Slurry Pleurodesis. [PDF]

Cureus, 2020
Objective Talc slurry pleurodesis (TSP) can lead to permanent small loculations. Intrapleural tissue plasminogen activator (tPA) breaks down loculations, and therefore may improve results but may also inhibit pleurodesis.
Bellini A, Tarrazzi F, Tami C, Patino SH, Block M.   +4 more
europepmc   +4 more sources

Malignant pleural effusions and the role of talc poudrage and talc slurry: a systematic review and meta-analysis [v2; ref status: indexed, http://f1000r.es/52v] [PDF]

F1000Research, 2015
Background: Malignant Pleural Effusion (MPE) is common with advanced malignancy. Palliative care with minimal adverse events is the cornerstone of management.
Srinivas Mummadi, Anusha Kumbam, Peter Y. Hahn   +2 more
doaj   +3 more sources

Risk factors related to pleural empyema after talc slurry pleurodesis. [PDF]

Clinics (Sao Paulo), 2022
Empyema is a complication of talc-pleurodesis that may lead to further surgical intervention and death. Therefore, the present study's objective was to identify the risk factors for the development of post-pleurodesis empyema after talc slurry pleurodesis in order to better select patients for this procedure and minimize its morbidity.Patients with ...
D'Ambrosio PD, de Araújo PHXN, Junior ER, Filho MR, Pêgo-Fernandes PM, Terra RM.   +5 more
europepmc   +6 more sources

Predictors of talc slurry pleurodesis success in patients with malignant pleural effusions

Revista Portuguesa de Pneumologia (English Edition), 2017
Introduction: Malignant pleural effusions are an important burden of malignant disease. Slurry talc pleurodesis remains one of the most common and effective therapeutic options.
P.S. Santos, M.A. Marques, C. Cruz, H. Monteiro, F. Fradinho   +4 more
doaj   +4 more sources

A Comparison of the Efficacies of OK-432 and Talc Slurry for Pleurodesis in Patients with Prolonged Air Leak after Pulmonary Resection. [PDF]

Ann Thorac Cardiovasc Surg, 2023
Purpose: A prolonged air leak (PAL) is one of the common postoperative complications of pulmonary resection. The aim of this study was to evaluate the efficacy and safety of pleurodesis with sterile talc or OK-432 for postoperative air leak.
Watanabe T, Yamauchi Y, Takeyama R, Kohmaru S, Dejima H, Saito Y, Sakao Y.   +6 more
europepmc   +2 more sources

Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.

JAMA, 2020
Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a common and effective treatment. There are no reliable data, however, regarding the optimal method for talc delivery, leading to differences in practice and ...
Bhatnagar R, Piotrowska HEG, Laskawiec-Szkonter M, Kahan BC, Luengo-Fernandez R, Pepperell JCT, Evison MD, Holme J, Al-Aloul M, Psallidas I, Lim WS, Blyth KG, Roberts ME, Cox G, Downer NJ, Herre J, Sivasothy P, Menzies D, Munavvar M, Kyi MM, Ahmed L, West AG, Harrison RN, Prudon B, Hettiarachchi G, Chakrabarti B, Kavidasan A, Sutton BP, Zahan-Evans NJ, Quaddy JL, Edey AJ, Clive AO, Walker SP, Little MHR, Mei XW, Harvey JE, Hooper CE, Davies HE, Slade M, Sivier M, Miller RF, Rahman NM, Maskell NA.   +42 more
europepmc   +2 more sources

Effectiveness and Safety of Talc Slurry Pleurodesis in the Treatment of Patients with Malignant Pleural Effusion and Low Karnofsky Performance Status Scores. [PDF]

J Clin Med
Background/Objectives: Malignant pleural effusion is a common and distressing complication of advanced cancer, often resulting in severe symptoms such as dyspnoea, which significantly impacts patients’ quality of life.
Kastrati E, Hasani A, Gradica F, Isufaj Haliti T, Bolat A, Hoxha I.   +5 more
europepmc   +2 more sources

OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management. [PDF]

BMJ Open, 2016
Introduction The development of malignant pleural effusion (MPE) results in disabling breathlessness, pain and reduced physical capability with treatment a palliative strategy.
Sivakumar P, Douiri A, West A, Rao D, Warwick G, Chen T, Ahmed L.   +6 more
europepmc   +2 more sources